Literature DB >> 15979999

Chemokine expression is dysregulated in the endometrium of women using progestin-only contraceptives and correlates to elevated recruitment of distinct leukocyte populations.

Rebecca L Jones1, Naomi B Morison, Natalie J Hannan, Hilary O D Critchley, Lois A Salamonsen.   

Abstract

BACKGROUND: Breakthrough bleeding (BTB) is the most common reason for discontinuation of progestin-only (p-only) contraceptives, yet the causes are unknown. Use of p-only contraceptives is associated with elevated influx of endometrial leukocytes, similar to that observed perimenstrually or within decidualized endometrium. We hypothesized that chemokine expression is altered in women using p-only contraceptives, leading to abnormal leukocyte recruitment and BTB.
METHODS: Expression of eight highly abundant endometrial chemokines was examined using immunohistochemistry and real-time PCR, in endometria from women using subdermal and intrauterine levonorgestrel and correlated to leukocyte subpopulations.
RESULTS: Macrophage-derived chemokine (MDC), hemofiltrate CC chemokine-1 (HCC-1), monocyte chemoattractant protein-3 (MCP-3), interleukin-8 (IL-8) and eotaxin were strongly produced by epithelial glands, comparable to levels in premenstrual phase endometrium. Stromal cells were negative for chemokines in atrophic/shedding endometria, but intensely positive in highly decidualized tissues for MDC, MCP-3, HCC-1 and 6Ckine. Macrophage inflammatory protein-1beta (MIP-1b) and HCC-4 were suppressed in all p-exposed endometria.
CONCLUSIONS: These data demonstrate that chemokine expression is dysregulated in p-exposed endometria, consistent with the morphological appearance of the endometrium and the leukocyte subsets present. This reinforces a potential role for chemokines in the elevated leukocyte recruitment that contributes to endometrial fragility and BTB.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15979999     DOI: 10.1093/humrep/dei140

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

1.  Progestin-Containing Contraceptives Alter Expression of Host Defense-Related Genes of the Endometrium and Cervix.

Authors:  Gabriel A Goldfien; Fatima Barragan; Joseph Chen; Margaret Takeda; Juan C Irwin; Jean Perry; Ruth M Greenblatt; Karen K Smith-McCune; Linda C Giudice
Journal:  Reprod Sci       Date:  2015-01-28       Impact factor: 3.060

2.  Glucocorticoid-independent repression of tumor necrosis factor (TNF) alpha-stimulated interleukin (IL)-6 expression by the glucocorticoid receptor: a potential mechanism for protection against an excessive inflammatory response.

Authors:  Nicolette J D Verhoog; Andrea Du Toit; Chanel Avenant; Janet P Hapgood
Journal:  J Biol Chem       Date:  2011-04-07       Impact factor: 5.157

Review 3.  Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis.

Authors:  Fernando M Reis; Felice Petraglia; Robert N Taylor
Journal:  Hum Reprod Update       Date:  2013-03-28       Impact factor: 15.610

Review 4.  Decidualized human endometrial stromal cells mediate hemostasis, angiogenesis, and abnormal uterine bleeding.

Authors:  Charles J Lockwood; Graciela Krikun; Martha Hickey; S Joseph Huang; Frederick Schatz
Journal:  Reprod Sci       Date:  2009-02       Impact factor: 3.060

5.  Immunomodulatory factors in cervicovaginal secretions from pregnant and non-pregnant women: a cross-sectional study.

Authors:  Jan Walter; Linda Fraga; Melanie J Orin; William D Decker; Theresa Gipps; Alice Stek; Grace M Aldrovandi
Journal:  BMC Infect Dis       Date:  2011-09-30       Impact factor: 3.090

6.  Progestins Related to Progesterone and Testosterone Elicit Divergent Human Endometrial Transcriptomes and Biofunctions.

Authors:  Sahar Houshdaran; Joseph C Chen; Júlia Vallvé-Juanico; Shayna Balayan; Kim Chi Vo; Karen Smith-McCune; Ruth M Greenblatt; Juan C Irwin; Linda C Giudice
Journal:  Int J Mol Sci       Date:  2020-04-09       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.